Home / current
Trials
Treatment Guidelines
PENTA Network
 
Committees
 
Clinical centres
Training
Key publications
All publications
Contacts
Other Activities
Risk calculator
Links
Area for PENTA network members (password
needed)
|
   
The Paediatric European Network for the treatment of
AIDS (PENTA) was established in 1991 as a collaboration between paediatric
HIV centres in Europe. The trials are co-ordinated by the HIV Division
of MRC Clinical Trials
Unit , London and ANRS, INSERM SC10, Paris and PHPT in Chiang Mai,
Thailand for some trials. Certain trials are run in collaboration with
the NICHD and IMPAACT in the USA.
The PENTA Steering Committee, chaired by Dr Carlo Giaquinto
from Italy, includes representatives from all participating European countries.
A core Executive committee co-opts specialists where appropriate for the
co-ordination of an individual trial. Virology, immunology and pharmacokinetic
committees advise the Steering Committee and plans protocol substudies.
PENTA trials are principally funded by the EU through
BIOMED II, by governmental and regional bodies in France, Italy, Spain
and the UK. Support from the pharmaceutical and biotechnology companies
for individual trials.
Objectives
- Address questions about treatment for children with HIV which cannot
be answered in adults principally because:
- natural history of vertical HIV infection differs
- tolerance of drugs may be different
- Collaboration with adult trials networks and PACTG
- evaluate primarily safety and tolerability in children to parallel
efficacy trials in adults
PENTA Executive Committee
Jean-Pierre Aboulker, INSERM SC10, Paris
Abdel Babiker, MRC Clinical Trials Unit, London
David Burger, Radboud University Medical Center Nijmegen
Alexandra Compagnucci,
INSERM SC10, Paris
Janet Darbyshire, MRC Clinical Trials Unit
Carlo Giaquinto, Università di Padova
Diana Gibb, MRC Clinical Trials Unit, London
Hannah Green, MRC Clinical Trials Unit, London
Nigel Klein, Insitute of Child Health, London
Hermione Lyall, St Marys'
Hospital, London
Deenan Pillay, University College London
Yacine Saïdi, INSERM SC10, Paris
PENTA Steering Committee
Paediatricians and Specialists in Infectious Diseases:
- Argentina: Rosa Bologna
- Belgium: Jack Levy
- Brazil: Marinella Della Negra
- Denmark: Nils Valerius
- France: Albert Faye
- Germany: Ilse Grosch-Wörner, Tim Nieheus
- Ireland, Karina Butler
- Italy: Carlo Giaquinto (Chair), Pier Angelo
Tovo, Stefania Bernardi, Raffaella Rosso
- Netherlands: Henriette Scherpbier, Ronald De Groot
- Poland: Magdalena Marczynska
- Portugal:
- Romania: Don Duiculescu, Martina Mardarescu
- Spain: Maria-José Mellado Pena, José Tomas Ramos Amador
- Sweden: Eric Belfrage
- Switzerland: David Nadal, Christoph Rudin
- Thailand: Jintanat Ananworanich
- UK: Mike Sharland, Steve
Welch, Catherine Peckham
Training
- Hermione Lyall, UK
- Guido Castelli-Gattinara, Italy
Community Representatives
- Polly Clayden, i-base, UK
- Milena Stevanovic, Solidarité Enfants Sida
European Aids Treatment Group (EATG), Macedonia
Co-ordinating Trials Centres:
For trials:
- PENPACT 1: Gareth Tudor-Willams, London
- PENTA 17: Uwe Wintergerst, Braunau
ECS link:
- Claire Thorne, ICH, London
Data and Safety Monitoring Committee
- Catherine Hill (Chair), Statistician, Institut Gustave Roussy, Paris,
France
- Anton Pozniak, GU Physician, Chelsea and Westminster Hospital,
London, UK
- Stefano Vella, Istituto Superiore di Sanità, Roma, Italy
Philippe Lepage, Professor of Paediatrics, University of Liège, Belgium
Virology/Immunology Committee
- Anita De Rossi, Padova, Italy
- Nigel Klein, London, UK
- Maria Muñoz Fernandez, Madrid, Spain
- Nicole Ngo, Chiang Mai, Thailand
- Deenan Pillay, London, UK
Pharmacology Committee
- Evelyne Jacqz-Aigrain, Paris, France
- David Burger, Nijmegen, the Netherlands
- Tim Cressey, Chiang Mai, Thailand
- Saye Khoo, Liverpool, UK
- Mario Regazzi, Pavia, Italy
- Jean Marc Tréluyer, Paris, France
Back to Top
|